• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Sunday, July 5, 2026
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

After the White House Conference on Hunger, Nutrition, and Health, the Obesity Medicine Association urges additional action be taken to address the obesity epidemic

Bioengineer by Bioengineer
October 5, 2022
in Health
Reading Time: 3 mins read
0
Obesity Medicine Association (OMA)
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

Denver, CO – The Obesity Medicine Association (OMA) responds to the Biden-⁠Harris Administration’s National Strategy on Hunger, Nutrition, and Health, which set forth important strategies for addressing the obesity crisis that now impacts over 100 million Americans. OMA applauds the White House’s commitment to improve access to healthy foods and physical activity for the millions of Americans struggling with food insecurity and diet-related diseases including obesity. However, the reality is that most American health insurers simply don’t cover obesity care services including pharmacotherapy and surgery.

Obesity Medicine Association (OMA)

Credit: OMA

Denver, CO – The Obesity Medicine Association (OMA) responds to the Biden-⁠Harris Administration’s National Strategy on Hunger, Nutrition, and Health, which set forth important strategies for addressing the obesity crisis that now impacts over 100 million Americans. OMA applauds the White House’s commitment to improve access to healthy foods and physical activity for the millions of Americans struggling with food insecurity and diet-related diseases including obesity. However, the reality is that most American health insurers simply don’t cover obesity care services including pharmacotherapy and surgery.

Today, the disease of obesity affects 42% of Americans, with women and minorities carrying a disproportionate burden of the disease. While access to healthy foods and physical activity options is a good first step, once a person has the disease of obesity, it is inadequate to stop further weight gain or to reverse the disease. Obesity causes countless downstream health consequences, including over 236 medical conditions such as diabetes and heart disease as well as 13 forms of cancer. Further, obesity shortens the lifespan by 6-8 years for those who are affected.

This is why at the OMA, in addition to teaching health care providers about evidence-based effective nutritional and physical activity interventions, we additionally focus on intensive lifestyle intervention to address the environmental influences that contribute to the obesity, including anti-obesity pharmacotherapy, and for select patients, bariatric and metabolic surgery.

Unfortunately, the current standard of care offered to people living with obesity is poor. Often the obesity is not diagnosed, and it is estimated that only 1-2% of people living with obesity receive the full spectrum of evidence-based care. This is in contrast to other chronic diseases like Type II diabetes, where over 85% of people receive recommended treatments including office visits, screening tests, and prescription medications.

The reality is that most American health insurers simply don’t cover obesity care services including pharmacotherapy and surgery, and those that do cover these therapies often have severe restrictions in place. For example, Medicare recipients are barred from using FDA-approved anti-obesity pharmacotherapy due to old and outdated language, and while Medicare will pay for intensive lifestyle intervention, it restricts these payments to the primary care provider, who isn’t typically trained to offer this intervention.

We urge the White House to take a close look at the Treat and Reduce Obesity Act (TROA). This act has broad bipartisan support and it seeks to remove barriers to the full spectrum of obesity care services as it relates to Medicare recipients. Enactment of TROA would allow Medicare plans to cover anti-obesity pharmacotherapy, and it would increase the reach of behavioral interventions by allowing registered dietitians and other health professionals with proper training to work with this important population.

People living with obesity deserve the same level of care as people living with other chronic diseases like diabetes. Simply improving food choices and access to physical activity would not be enough to treat diabetes, and similarly, is not adequate to treat the disease of obesity.

About the Obesity Medicine Association

The Obesity Medicine Association is the largest organization of physicians, nurse practitioners, physician assistants, and other healthcare providers dedicated to preventing, treating, and reversing the disease of obesity. Members of OMA believe treating obesity requires a scientific and individualized clinical approach comprised of nutrition, physical activity, behavior, and medication. When personalized, this comprehensive approach helps patients achieve their weight and health goals. Visit obesitymedicine.org to learn more.



Share12Tweet8Share2ShareShareShare2

Related Posts

Lysine Pyruvylation Links Glycolysis to Epigenetics

July 4, 2026

Personalized Neoantigen Dendritic Cell Vaccine in Glioblastoma

July 4, 2026

Decoding Neural Timescales: A Computational Viewpoint

July 4, 2026

Uncovering C5aR2: Unique Signaling and Agonists

July 4, 2026

POPULAR NEWS

  • Detection of EDCs in Breast Milk and Infant Urine Up to Six Months Highlights Early Exposure Risks

    77 shares
    Share 31 Tweet 19
  • Saying Goodbye to PGY-6: Pediatric Fellowship Realities

    103 shares
    Share 41 Tweet 26
  • New Drug Candidate Developed at McMaster Shows Potential for Treating Brain Cancer

    58 shares
    Share 23 Tweet 15
  • KTU Researchers Explore Ultrasound’s Role in Enhancing Blood Flow Beyond Diagnostics

    53 shares
    Share 21 Tweet 13

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Quasi-Bound States Boost Quantum Well Photoresponse

Lysine Pyruvylation Links Glycolysis to Epigenetics

Multiphysics Coupling: Single vs. Multiple DeepONet Branches

Subscribe to Blog via Email

Success! An email was just sent to confirm your subscription. Please find the email now and click 'Confirm' to start subscribing.

Join 83 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.